Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


HOFFMAN ROBERT Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2022 4 Hoffman Robert E. (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.
Txns: Granted 400,145 shares @ $0
Granted 1,200,634 options to buy @ $0.1757, valued at $211k
02/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2021 4 HOFFMAN ROBERT (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.
Txns: Granted 3,519,170 options to buy @ $0.96, valued at $3.4M
09/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,000 options to buy @ $21.54, valued at $495.4k
09/17/2020 4 HOFFMAN ROBERT (Director) has filed a Form 4 on Kintara Therapeutics, Inc.
Txns: Granted 120,000 options to buy @ $1.7, valued at $204k
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/09/2020 4 HOFFMAN ROBERT (Former Director) has filed a Form 4 on Aravive, Inc.
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2019 4 HOFFMAN ROBERT (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 7,500 options @ $5.77, valued at $43.3k
09/09/2019 4 HOFFMAN ROBERT (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns: Granted 39,567 options to buy @ $0.61, valued at $24.1k
Granted 35,433 options to buy @ $0.61, valued at $21.6k
06/27/2019 4 HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 13,000 options to buy @ $19.55, valued at $254.2k
05/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2019 4/A HOFFMAN ROBERT (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 7,500 options @ $0
Granted 4,688 options @ $0
01/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/18/2018 4 HOFFMAN ROBERT (CFO & SVP, Finance) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 71,000 options to buy @ $24.97, valued at $1.8M
11/13/2018 4 HOFFMAN ROBERT (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $0.6099, valued at $24.4k
10/16/2018 3 HOFFMAN ROBERT (Director) has filed a Form 3 on Aravive, Inc.
07/03/2018 4 HOFFMAN ROBERT (CFO & SVP, Finance) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 744 shares @ $13.2175, valued at $9.8k
Sold 28,940 shares @ $38.1516, valued at $1.1M
Sold 1,060 shares @ $38.7953, valued at $41.1k
Exercised 30,000 options to buy @ $15.3, valued at $459k
06/08/2018 4 HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 13,000 options to buy @ $16.35, valued at $212.6k
04/17/2018 4 HOFFMAN ROBERT (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.
Txns: Granted 36,000 options to buy @ $1.06, valued at $38.2k
Granted 200,000 rights @ $0
04/12/2018 3 HOFFMAN ROBERT (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc.
12/20/2017 4 HOFFMAN ROBERT (CFO & SVP, Finance) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 536 shares @ $13.0475, valued at $7k
Granted 56,667 options to buy @ $17, valued at $963.3k
11/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2017 4 HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 10,000 options to buy @ $8.6, valued at $86k
05/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/24/2017 3 Form 3 - Initial statement of beneficial ownership of securities
04/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/21/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/07/2016 3 Form 3 - Initial statement of beneficial ownership of securities
08/30/2016 4 HOFFMAN ROBERT (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 4,100 options to buy @ $5, valued at $20.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy